Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Methoxyamine

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Methoxyamine: Patents, clinical trial progress, indications

Methoxyamine is an investigational drug.

There have been 6 clinical trials for Methoxyamine. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2015.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Lymphoma, and Lung Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Case Comprehensive Cancer Center, and [disabled in preview].

There are three US patents protecting this investigational drug and thirty-five international patents.

Recent Clinical Trials for Methoxyamine
Methoxyamine and Temozolomide in Treating Patients With Recurrent GlioblastomaNational Cancer Institute (NCI)Phase 2
Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung CancerNational Cancer Institute (NCI)Phase 1
Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Cisplatin and PemetrexedNational Cancer Institute (NCI)Phase 1/Phase 2

See all Methoxyamine clinical trials

Clinical Trial Summary for Methoxyamine

Top disease conditions for Methoxyamine
Top clinical trial sponsors for Methoxyamine

See all Methoxyamine clinical trials

US Patents for Methoxyamine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Methoxyamine   See Pricing 4-substituted pyrazolo[3,4-d]pyrimidine derivatives Ortho Pharmaceutical Corporation (Raritan, NJ)   See Pricing
Methoxyamine   See Pricing Macrolide compounds American Cyanamid Company (Stamford, CT)   See Pricing
Methoxyamine   See Pricing Benzo[1,8]naphthyridine derivatives, their preparation and the compositions which contain them Laboratoire Roger Bellon (Seine, FR)   See Pricing
Methoxyamine   See Pricing Inosose derivatives, production and use thereof Takeda Chemical Industries, Ltd. (Osaka, JP)   See Pricing
Methoxyamine   See Pricing 7-substituted bicyclic pyrazolidinones Eli Lilly and Company (Indianapolis, IN)   See Pricing
Methoxyamine   See Pricing Process for the preparation of substituted 3-amino-2 (benzoyl)-acrylic acid esters, and a process for the preparation of intermediates for antibacterial active compounds from these compounds Chemie Linz Gesellschaft m.b.H. (Linz, AT)   See Pricing
Methoxyamine   See Pricing Optically active hydroxybenzylamine Sumitomo Chemical Company, Limited (Osaka, JP)   See Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Methoxyamine

Drugname Country Document Number Estimated Expiration Related US Patent
Methoxyamine Australia 3088389 2008-03-03   See Pricing
Methoxyamine Australia 612797 2008-03-03   See Pricing
Methoxyamine China 1030605 2008-03-03   See Pricing
Methoxyamine China 1036766 2008-03-03   See Pricing
Methoxyamine Denmark 101689 2008-03-03   See Pricing
Methoxyamine European Patent Office 0331510 2008-03-03   See Pricing
Methoxyamine Finland 891004 2008-03-03   See Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.